Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allopurinol and Chronic Kidney Disease.

The New England journal of medicine·2020
Same author

UWB-Based Self-Localization Strategies: A Novel ICP-Based Method and a Comparative Assessment for Noisy-Ranges-Prone Environments.

Sensors (Basel, Switzerland)·2020
Same author

Views of Farmers and Industrial Entrepreneurs on The Iberian Pig Quality Standard: An In-Depth Interview Research Study.

Animals : an open access journal from MDPI·2020
Same author

IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Biomolecules·2020
Same author

Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2020
Same author

The effect of energy restriction on development and progression of chronic kidney disease: review of the current evidence.

The British journal of nutrition·2020

Related Experiment Video

Updated: May 23, 2026

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

Implementation of proteomic biomarkers: making it work.

Harald Mischak1, John P A Ioannidis, Angel Argiles

  • 1BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Harald.Mischak@glasgow.ac.uk

European Journal of Clinical Investigation
|April 24, 2012
PubMed
Summary

Despite numerous proteomic biomarkers, few reach clinical practice. This study identifies implementation hurdles beyond verification and proposes a stakeholder-driven roadmap to accelerate the integration of validated biomarkers into healthcare.

More Related Videos

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Related Experiment Videos

Last Updated: May 23, 2026

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Area of Science:

  • Biomarker Discovery and Implementation Science
  • Proteomics in Clinical Practice
  • Translational Medicine

Background:

  • Numerous proteomic biomarkers have been identified but rarely implemented in clinical settings.
  • Existing challenges extend beyond initial biomarker discovery and validation.
  • Hurdles to implementation significantly impede the translation of research findings into patient care.

Purpose of the Study:

  • To investigate the reasons for the limited implementation of proteomic biomarkers in medical practice.
  • To identify major obstacles in the downstream processes of biomarker verification and qualification.
  • To propose solutions and a roadmap for facilitating biomarker implementation.

Main Methods:

  • Analysis of challenges in biomarker discovery, validation, and qualification.
  • Identification of implementation barriers including specimen access, funding, and interventional trial validation.
  • Development of a stakeholder-inclusive implementation roadmap.

Main Results:

  • Suboptimal discovery and validation platforms hinder biomarker qualification.
  • Limited specimen access, funding, and the need for interventional validation are key barriers.
  • Communication gaps between diverse stakeholders complicate implementation efforts.

Conclusions:

  • Successful biomarker implementation requires addressing challenges beyond discovery and validation.
  • A collaborative roadmap involving clinicians, researchers, industry, and regulatory bodies is proposed.
  • Stakeholder engagement is crucial for efficient biomarker evaluation and clinical integration.